FIELD: medicine.
SUBSTANCE: invention is intended for differential diagnostics of various nosological forms of autoimmune liver diseases (AILD). To carry out differential diagnostics of autoimmune liver diseases clinical-and-laboratory, morphological and immunomorphologcal tests with immunhistochemical determination of bcl-2 in liver tissue are performed. Comparative analysis of content of bcl-2 positive cells is carried out and the level of percent content of bcl-2 is determined. Differential diagnostics is carried out between primary biliary cirrhosis if value is 66%-100% and cross syndrome - autoimmune hepatitis/primary biliary cirrhosis - lower than 66%; between autoimmune hepatitis - 33%-66% and primary biliary cirrhosis - 66%-100%; between autoimmune hepatitis 33%-66% and chronic viral hepatitis C - 0%-33%.
EFFECT: application of invention makes it possible to increase reliability of differential diagnostics of cross syndromes of autoimmune liver diseases, with further optimisation of therapy, depending on stated diagnosis.
1 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR CROSSED FORMS OF AUTOIMMUNE LIVER DISEASES | 2011 |
|
RU2477486C1 |
METHOD OF DIFFERENTIATING HEPATIC FIBROSIS IN CHRONIC VIRAL HEPATITIS B AND AUTOIMMUNE LIVER INJURIES | 2018 |
|
RU2701723C1 |
METHOD FOR SELECTING TREATMENT APPROACH IN AUTOIMMUNE CHIASM OF AUTOIMMUNE HEPATITIS AND PRIMARY BILIARY CIRRHOSIS PATIENTS | 2006 |
|
RU2310856C1 |
METHOD FOR PRODUCING SEMI-QUANTITATIVE ESTIMATES OF CHANGES IN CHRONIC VIRAL HEPATITIS-INJURED LIVER BIOPTATES | 2002 |
|
RU2227298C2 |
METHOD FOR DIFFERENTIATING CAUSES OF DEVELOPMENT OF INITIAL STAGE OF HEPATIC FIBROSIS IN CHRONIC VIRAL HEPATITIDES B AND C | 2019 |
|
RU2759672C2 |
METHOD FOR DIAGNOSING CHOLESTATIC SYNDROME | 2021 |
|
RU2774175C1 |
METHOD OF TREATMENT HEPATIC CIRRHOSIS OF VARIOUS ETIOLOGY | 2015 |
|
RU2593007C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR LIVER DISEASES OF VARIOUS AETIOLOGIES ACCOMPANIED WITH INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386969C2 |
ANTAGONISTS OF ALPHAVBETA3 AND ALPHAVBETA6 INTEGRINS AND ANTIFIBROTIC AGENTS | 2004 |
|
RU2388472C2 |
METHOD FOR PREDICTING CIRRHOTIC STAGE OF CHRONIC VIRAL HEPATITIS | 2005 |
|
RU2321353C2 |
Authors
Dates
2015-10-27—Published
2014-03-25—Filed